androsta-1,4,6-triene-3,17-dione has been researched along with 9,10-dimethyl-1,2-benzanthracene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Garrett, WM; Hendrickson, JR; Tsai-Morris, CH | 1 |
| Brodie, AM; Brodie, HJ; Garrett, WM; Hendrickson, JR; Marsh, DA; Tsai-Morris, CH | 1 |
2 other study(ies) available for androsta-1,4,6-triene-3,17-dione and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Castration; Estrogens; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Ovary; Oxidoreductases; Rats | 1982 |
Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstatrienes; Animals; Antineoplastic Agents; Aromatase Inhibitors; Female; Follicle Stimulating Hormone; In Vitro Techniques; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovary; Oxidoreductases; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1982 |